On Thursday shares of JetBlue Airways Corporation (NASDAQ:JBLU) closed at $18.52. Company’s sales growth for last 5 years was 12.10% and EPS growth for next 5 years is recorded as 42.70%. JetBlue Airways Corporation (NASDAQ:JBLU) will reduce its seasonal flights out of Long Beach Airport when its summer schedule goes into effect, although the airline will not eliminate any destinations from its current slate of outbound flights.
Akebia Therapeutics, Inc. (NASDAQ:AKBA) in last trading activity advanced 0.59% to close at $10.29. Company weekly performance is -20.85% while its quarterly performance stands at -10.83%. Akebia Therapeutics, Inc. (NASDAQ:AKBA) is -66.81% away from its 52 week high. Akebia Therapeutics (NASDAQ:AKBA) announced the presentation of results from its Phase 2b trial of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease (CKD) at the International Society of Nephrology’s biennial World Congress of Nephrology (WCN), presented in Cape Town, South Africa from March 13-17, 2015. In this Phase 2b trial, treatment with AKB-6548 controlled hemoglobin (HGB) levels in a sustained manner and in the clinically relevant range, producing a coordinated physiologic response to resolve anemia, while avoiding excessive fluctuations in HGB levels which have been associated with increased cardiovascular risks.
On last trading day Ruckus Wireless, Inc. (NYSE:RKUS) decreased -0.81% to close at $12.17. Its volatility for the week is 2.62% while volatility for the month is 3.52%. RKUS’s sales growth for past 5 years was 49.10% and its EPS growth for past 5 years was 16.20%. Ruckus Wireless, Inc. (NYSE:RKUS) monthly performance is 2.61%. Ruckus Wireless, Inc. (NYSE:RKUS) has announced that Italian broadband operator Fastweb has selected an indoor/outdoor Ruckus Smart Wi-Fi network to provide high-capacity, high-speed public access and Wi-Fi location services throughout the Fiera Milano, the third largest exhibition centre in the world.
Columbia Laboratories Inc. (NASDAQ:CBRX) has 2.98% insider ownership while its institutional ownership stands at 24.50%. In last trading activity company’s stock closed at $6.28. On March 18, Columbia Laboratories, Inc. (Nasdaq:CBRX) announced financial results for the three- and twelve-month periods ended December 31, 2014. Revenues increased 11% year-over-year to $32.5 million in the year ended December 31, 2014, as compared to $29.2 million in the previous year.
On last trading day Central Garden & Pet Company (NASDAQ:CENT) decreased -1.18% to close at $10.03. Its volatility for the week is 2.84% while volatility for the month is 2.83%. CENT’s sales growth for past 5 years was -0.10% and its EPS growth for past 5 years was -28.10%. Central Garden & Pet Company (NASDAQ:CENT) monthly performance is 9.74%. Zacks downgraded shares of Central Garden & Pet Company (NASDAQ:CENT) from a strong-buy rating to a buy rating. Their analysts now have a $12.00 price target on that stock.